EM1608E "Rethinking Diabetes Screening and Case Finding Strategies in Clinical Practice: Who’s Really at Risk?" (IM GR-082616)
This presentation reviews the principles of population-based screening in the context of type 2 diabetes. In the absence of evidence supporting population-based screening, opportunistic screening and case finding strategies are discussed in the context of clinical practice. Approaches to identifying patients at high risk for diabetes including screening guidelines and risk scores are examined. We define and discuss the glucose history in the context of electronic medical record data and explore its potential use in developing EMR-based diabetes risk scores integrated with clinical decision support.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe the evidence for and against population-based screening for type 2 diabetes
- Understand key differences in US diabetes screening guidelines and how their performance varies in different clinical populations
- Understand the utility of diabetes risk scores and barriers to the use of current risk scores in clinical practice
- Define glucose history and its association with undiagnosed diabetes
Michael Bowen, M.D., M.P.H., M.S.C.S.
Dedman Family Scholar in Clinical Care
Division of General Internal Medicine
- 1.00 AMA